Nanotherapeutic that can cross blood-brain barrier reported in journal
The University of Delaware’s Emily Day is a part of a team of researchers that has developed a nanotherapeutic capable of penetrating the blood-brain barrier.
Previously believed impossible, the groundbreaking development could have implications in the treatment of Glioblastoma multiforme (GBM), a lethal form of malignant brain tumors that is considered one of the deadliest human cancers. It may also benefit research for neurodegenerative diseases such as Parkinson’s disease, traumatic brain injury and multiple forms of cancer.
Led by researchers at Northwestern University, where Day conducted post-doctoral research, the team discovered that spherical nucleic acids (SNAs), tiny spherical gold nanoparticles densely coated with nucleic acids, have unique properties that allow them to pass through the blood-brain barrier and attack brain cancer.
The technology works by targeting Bcl2L12, a gene important in tumor progression.
“We believe that the SNA particles pass through by binding to scavenger receptors present in the cells lining the blood-brain barrier,” Day explained. “Once past the barrier, the SNA particles travel through the brain tissue and infiltrate tumor cells, where they interfere with the tumor cell’s genetic machinery to prevent the Bcl2L12 gene from being expressed.”
When administered systemically in cell and rodent models, the SNAs delivered nucleic acids to tumors without help from cationic carriers or other chemical modifications, lowered the expression of Bcl2L12 and effectively reduced tumor burden.
“Generally speaking we saw about a 20 percent increase in animal survival rates with this treatment, and a five-fold reduction in tumor growth without adverse side effects,” said Day, assistant professor of biomedical engineering at UD.
This discovery establishes SNAs as a promising new class of therapeutic gene regulation agents capable of treating disease through systemic injection, according to the research team’s findings published as a cover article in Science Translational Medicine, a publication of the American Association for the Advancement of Science.
Co-first authors on the paper were Day, Samuel Jensen and Caroline Ko, and their interdisciplinary team included researchers from Northwestern University’s departments of chemistry, biomedical engineering, molecular biosciences, neurology, neurobiology, and the International Institute for Nanotechnology. The research was led by Chad Mirkin, professor in Northwestern University’s Department of Chemistry, and Alexander Stegh, professor, in the Department of Neurology.
Future work on the project will include studies to determine safety and efficacy issues necessary for human trials and scaling the technology for manufacturing.
The Latest Google Headlines on:
Brain cancer
[google_news title=”” keyword=”Brain cancer” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Brain cancer
- Definitive Therapy to the Primary Site Improves Survival in Brain-Only Metastatic NSCLCon April 26, 2024 at 7:01 am
Definitive treatment to the primary site improves overall and cancer-specific survival among patients with brain-only NSCLC metastases, a recent retrospective study shows.
- Isabella Strahan Gives Brain Cancer Treatment Update After Unexpected Surgeryon April 26, 2024 at 4:30 am
Michael Strahan’s daughter Isabella Strahan shared a health update amid her ongoing brain cancer battle. She revealed her medulloblastoma diagnosis in January.
- Isabella Strahan shares day-in-the-life amid chemotherapy, brain tumor battleon April 25, 2024 at 2:00 pm
Isabella was just one month into her freshman year at the University of Southern California in Los Angeles last fall when she began experiencing headaches and nausea. After testing, doctors discovered ...
- Brain microdisplay: New device maps brain in real-time during surgeryon April 25, 2024 at 9:54 am
The device combines LEDs and an electrode grid to light up the brain during surgery. It will provide surgeons with real-time visual guidance.
- New Therapy Destroys Deadly Brain Tumor in Dayson April 25, 2024 at 6:30 am
A groundbreaking new therapy destroys deadly brain tumors within days. The new treatment, CAR T-cell therapy, helps treat glioblastoma.
- Michael Strahan’s daughter Isabella reacts to fan not knowing if she’s alive as she battles brain canceron April 24, 2024 at 6:20 am
The University of Southern California student and her dad, Michael Strahan, revealed her cancer diagnosis during “Good Morning America” in January.
- Isabella Strahan Shares Empowering Message Amid Brain Cancer Battleon April 24, 2024 at 6:19 am
Michael Strahan's 19-year-old daughter Isabella Strahan is taking her battle with medulloblastoma in stride and responded to fans about her progress.
- Day One takes on Novartis with FDA nod for Ojemda in broader common childhood brain tumor useon April 23, 2024 at 7:13 pm
Another drug is in town for common pediatric brain tumors. Compared with an incumbent offering from Novartis, the newcomer boasts an FDA approval covering a broader patient population. | Another drug ...
- Mini-colon and brain 'organoids' shed light on cancer and other diseaseson April 23, 2024 at 5:00 pm
When the researchers injected the cancerous cells into mice, the tumours looked similar to those seen in human colorectal cancer. The organoids accumulated fewer tumours when the researchers ...
- Isabella Strahan Responds to Fan Who Asks If She's 'Still Alive' amid Painful Brain Tumor Treatmenton April 23, 2024 at 4:01 pm
Isabella Strahan responded to a fan who asked if she is "still alive" amid her brain tumor diagnosis in a TikTok video.
The Latest Google Headlines on:
Nanotherapeutic
[google_news title=”” keyword=”nanotherapeutic” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Nanotherapeutic
- Feed has no items.